A multi-omics study reveals that impaired branched-chain amino acid (BCAA) catabolism is a key driver of sarcopenia, suggesting it as a potential therapeutic target.

2017). Therefore, studying and improving natural and cultivation conditions to obtain a balanced amino acid profile is important, as a balanced profile of EAA defines (in part) the quality of a ...

Dividend announcements are not available. No other corporate actions details are available.